Department of Cardiology and Internal Diseases, Military Institute of Medicine, Warsaw, Poland.
Department of Gastroenterology, Endocrinology and Internal Diseases, Military Institute of Medicine, Warsaw, Poland.
Front Endocrinol (Lausanne). 2020 Jun 24;11:418. doi: 10.3389/fendo.2020.00418. eCollection 2020.
Acromegaly is a rare disease that requires modern treatment to decrease the risk of mortality, mainly from vascular diseases. Identifying acromegalic patients with increased cardiovascular risk is challenging. Speckle-tracking echocardiography (STE) is a modern, well-validated, and reproducible method of assessing left ventricular longitudinal deformation and providing a sensitive assessment of myocardial contractility. We hypothesized that STE may be useful in evaluating subclinical dysfunction of the left heart in acromegalic patients, especially when a left ventricle (LV) assessment is completed with STE of the left atrium (LA). To assess the diagnostic value of speckle-tracking echocardiography in identifying the occurrence of LV and LA functional impairment in patients with acromegaly, in comparison to patients without this rare pituitary disease. Echocardiographic assessments of LV and LA function using the new STE method were performed in 60 subjects: 30 acromegalic (ACRO group) patients and a CONTROL group with 30 patients matched in terms of age, gender, systolic/diastolic pressure, and history of hypertension for at least 12 months. The ACRO group, compared to the CONTROL group, presented: (1) higher left ventricular mass (left ventricular mass index: 132 vs. 108 g/m, < 0.001) and, in consequence, more frequent LV hypertrophy (80.0 vs. 53.3%; = 0.028); (2) impaired LV systolic function measured by both left ventricular ejection fraction (LVEF) (63.4 vs. 66.9%, < 0.001) and global longitudinal strain (GLS) (-18.1 vs. -19.4%, = 0.023); (3) greater LA anteroposterior diameter (40.3 vs. 36.9 mm, = 0.003) and indexed left atrial volume (37.9 vs. 27.6 ml/m, < 0.001); and (4) impaired echocardiographic strain parameters corresponding with LA function. Acromegaly, even in young patients with good blood pressure control, may be associated with left ventricular hypertrophy and subclinical impairment of the left ventricular and left atrial mechanical function, which may be identified by speckle-tracking echocardiography. Further research in this area is necessary to clarify the prognostic value of these phenomena.
肢端肥大症是一种罕见的疾病,需要现代治疗来降低死亡率,主要是死于血管疾病。识别有心血管风险增加的肢端肥大症患者具有挑战性。斑点追踪超声心动图(STE)是一种评估左心室纵向变形的现代、经过良好验证且可重复的方法,并提供心肌收缩力的敏感评估。我们假设 STE 可能有助于评估肢端肥大症患者的左心亚临床功能障碍,尤其是当使用左心房(LA)STE 完成左心室(LV)评估时。为了评估斑点追踪超声心动图在识别肢端肥大症患者 LV 和 LA 功能障碍发生方面的诊断价值,并与没有这种罕见垂体疾病的患者进行比较。使用新的 STE 方法对 60 例患者的 LV 和 LA 功能进行超声心动图评估:30 例肢端肥大症(ACRO 组)患者和 30 例 CONTROL 组患者,这些患者在年龄、性别、收缩压/舒张压以及至少 12 个月的高血压病史方面相匹配。与 CONTROL 组相比,ACRO 组患者:(1)左心室质量更高(左心室质量指数:132 与 108 g/m,<0.001),因此更频繁地出现 LV 肥厚(80.0 与 53.3%;=0.028);(2)左心室射血分数(LVEF)(63.4 与 66.9%,<0.001)和整体纵向应变(GLS)(-18.1 与-19.4%,=0.023)均测量的 LV 收缩功能受损;(3)更大的 LA 前后直径(40.3 与 36.9 mm,=0.003)和指数化左心房容积(37.9 与 27.6 ml/m,<0.001);(4)LA 功能的超声心动图应变参数受损。即使在血压控制良好的年轻肢端肥大症患者中,肢端肥大症也可能与左心室肥厚和左心室和左心房机械功能的亚临床损伤相关,这些可以通过斑点追踪超声心动图来识别。需要进一步研究这一领域,以阐明这些现象的预后价值。